Population screening for colorectal cancer by flexible sigmoidoscopy or CT colonography: Study protocol for a multicenter randomized trial

Daniele Regge, Gabriella Iussich, Carlo Senore, Loredana Correale, Cesare Hassan, Alberto Bert, Stefania Montemezzi, Nereo Segnan

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Background: Colorectal cancer (CRC) is the second most prevalent type of cancer in Europe. A single flexible sigmoidoscopy (FS) screening at around the age of 60 years prevents about one-third of CRC cases. However, FS screens only the distal colon, and thus mortality from proximal CRC is unaffected. Computed tomography colonography (CTC) is a highly accurate examination that allows assessment of the entire colon. However, the benefit of CTC testing as a CRC screening test is uncertain. We designed a randomized trial to compare participation rate, detection rates, and costs between CTC (with computer-aided detection) and FS as primary tests for population-based screening.Methods/Design: An invitation letter to participate in a randomized screening trial comparing CTC versus FS will be mailed to a sample of 20,000 people aged 58 or 60 years, living in the Piedmont region and the Verona district of Italy. Individuals with a history of CRC, adenomas, inflammatory bowel disease, or recent colonoscopy, or with two first-degree relatives with CRC will be excluded from the study by their general practitioners. Individuals responding positively to the invitation letter will be then randomized to the intervention group (CTC) or control group (FS), and scheduled for the screening procedure. The primary outcome parameter of this part of the trial is the difference in advanced neoplasia detection between the two screening tests. Secondary outcomes are cost-effectiveness analysis, referral rates for colonoscopy induced by CTC versus FS, and the expected and perceived burden of the procedures. To compare participation rates for CTC versus FS, 2,000 additional eligible subjects will be randomly assigned to receive an invitation for screening with CTC or FS. In the CTC arm, non-responders will be offered fecal occult blood test (FOBT) as alternative screening test, while in the FS arm, non-responders will receive an invitation letter to undergo screening with either FOBT or CTC. Data on reasons for participation and non-participation will also be collected.Discussion: This study will provide reliable information concerning benefits and risks of the adoption of CTC as a mass screening intervention in comparison with FS. The trial will also evaluate the role of computer-aided detection in a screening setting.Trial registration: ClinicalTrials.gov Identifier: NCT01739608.

Original languageEnglish
Article number97
JournalTrials
Volume15
Issue number1
DOIs
Publication statusPublished - Mar 28 2014

Fingerprint

Computed Tomographic Colonography
Sigmoidoscopy
Multicenter Studies
Colorectal Neoplasms
Tomography
Population
Occult Blood
Hematologic Tests
Colonoscopy
Colon
Mass Screening
Inflammatory Bowel Diseases
Early Detection of Cancer
Adenoma
General Practitioners
Italy
Cost-Benefit Analysis
Neoplasms
Referral and Consultation

Keywords

  • Colorectal cancer
  • Computer-aided detection
  • CT colonography
  • Flexible sigmoidoscopy
  • Screening

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Pharmacology (medical)

Cite this

Population screening for colorectal cancer by flexible sigmoidoscopy or CT colonography : Study protocol for a multicenter randomized trial. / Regge, Daniele; Iussich, Gabriella; Senore, Carlo; Correale, Loredana; Hassan, Cesare; Bert, Alberto; Montemezzi, Stefania; Segnan, Nereo.

In: Trials, Vol. 15, No. 1, 97, 28.03.2014.

Research output: Contribution to journalArticle

Regge, Daniele ; Iussich, Gabriella ; Senore, Carlo ; Correale, Loredana ; Hassan, Cesare ; Bert, Alberto ; Montemezzi, Stefania ; Segnan, Nereo. / Population screening for colorectal cancer by flexible sigmoidoscopy or CT colonography : Study protocol for a multicenter randomized trial. In: Trials. 2014 ; Vol. 15, No. 1.
@article{02a25bf0ac094456b66d17045ad1022e,
title = "Population screening for colorectal cancer by flexible sigmoidoscopy or CT colonography: Study protocol for a multicenter randomized trial",
abstract = "Background: Colorectal cancer (CRC) is the second most prevalent type of cancer in Europe. A single flexible sigmoidoscopy (FS) screening at around the age of 60 years prevents about one-third of CRC cases. However, FS screens only the distal colon, and thus mortality from proximal CRC is unaffected. Computed tomography colonography (CTC) is a highly accurate examination that allows assessment of the entire colon. However, the benefit of CTC testing as a CRC screening test is uncertain. We designed a randomized trial to compare participation rate, detection rates, and costs between CTC (with computer-aided detection) and FS as primary tests for population-based screening.Methods/Design: An invitation letter to participate in a randomized screening trial comparing CTC versus FS will be mailed to a sample of 20,000 people aged 58 or 60 years, living in the Piedmont region and the Verona district of Italy. Individuals with a history of CRC, adenomas, inflammatory bowel disease, or recent colonoscopy, or with two first-degree relatives with CRC will be excluded from the study by their general practitioners. Individuals responding positively to the invitation letter will be then randomized to the intervention group (CTC) or control group (FS), and scheduled for the screening procedure. The primary outcome parameter of this part of the trial is the difference in advanced neoplasia detection between the two screening tests. Secondary outcomes are cost-effectiveness analysis, referral rates for colonoscopy induced by CTC versus FS, and the expected and perceived burden of the procedures. To compare participation rates for CTC versus FS, 2,000 additional eligible subjects will be randomly assigned to receive an invitation for screening with CTC or FS. In the CTC arm, non-responders will be offered fecal occult blood test (FOBT) as alternative screening test, while in the FS arm, non-responders will receive an invitation letter to undergo screening with either FOBT or CTC. Data on reasons for participation and non-participation will also be collected.Discussion: This study will provide reliable information concerning benefits and risks of the adoption of CTC as a mass screening intervention in comparison with FS. The trial will also evaluate the role of computer-aided detection in a screening setting.Trial registration: ClinicalTrials.gov Identifier: NCT01739608.",
keywords = "Colorectal cancer, Computer-aided detection, CT colonography, Flexible sigmoidoscopy, Screening",
author = "Daniele Regge and Gabriella Iussich and Carlo Senore and Loredana Correale and Cesare Hassan and Alberto Bert and Stefania Montemezzi and Nereo Segnan",
year = "2014",
month = "3",
day = "28",
doi = "10.1186/1745-6215-15-97",
language = "English",
volume = "15",
journal = "Trials",
issn = "1745-6215",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Population screening for colorectal cancer by flexible sigmoidoscopy or CT colonography

T2 - Study protocol for a multicenter randomized trial

AU - Regge, Daniele

AU - Iussich, Gabriella

AU - Senore, Carlo

AU - Correale, Loredana

AU - Hassan, Cesare

AU - Bert, Alberto

AU - Montemezzi, Stefania

AU - Segnan, Nereo

PY - 2014/3/28

Y1 - 2014/3/28

N2 - Background: Colorectal cancer (CRC) is the second most prevalent type of cancer in Europe. A single flexible sigmoidoscopy (FS) screening at around the age of 60 years prevents about one-third of CRC cases. However, FS screens only the distal colon, and thus mortality from proximal CRC is unaffected. Computed tomography colonography (CTC) is a highly accurate examination that allows assessment of the entire colon. However, the benefit of CTC testing as a CRC screening test is uncertain. We designed a randomized trial to compare participation rate, detection rates, and costs between CTC (with computer-aided detection) and FS as primary tests for population-based screening.Methods/Design: An invitation letter to participate in a randomized screening trial comparing CTC versus FS will be mailed to a sample of 20,000 people aged 58 or 60 years, living in the Piedmont region and the Verona district of Italy. Individuals with a history of CRC, adenomas, inflammatory bowel disease, or recent colonoscopy, or with two first-degree relatives with CRC will be excluded from the study by their general practitioners. Individuals responding positively to the invitation letter will be then randomized to the intervention group (CTC) or control group (FS), and scheduled for the screening procedure. The primary outcome parameter of this part of the trial is the difference in advanced neoplasia detection between the two screening tests. Secondary outcomes are cost-effectiveness analysis, referral rates for colonoscopy induced by CTC versus FS, and the expected and perceived burden of the procedures. To compare participation rates for CTC versus FS, 2,000 additional eligible subjects will be randomly assigned to receive an invitation for screening with CTC or FS. In the CTC arm, non-responders will be offered fecal occult blood test (FOBT) as alternative screening test, while in the FS arm, non-responders will receive an invitation letter to undergo screening with either FOBT or CTC. Data on reasons for participation and non-participation will also be collected.Discussion: This study will provide reliable information concerning benefits and risks of the adoption of CTC as a mass screening intervention in comparison with FS. The trial will also evaluate the role of computer-aided detection in a screening setting.Trial registration: ClinicalTrials.gov Identifier: NCT01739608.

AB - Background: Colorectal cancer (CRC) is the second most prevalent type of cancer in Europe. A single flexible sigmoidoscopy (FS) screening at around the age of 60 years prevents about one-third of CRC cases. However, FS screens only the distal colon, and thus mortality from proximal CRC is unaffected. Computed tomography colonography (CTC) is a highly accurate examination that allows assessment of the entire colon. However, the benefit of CTC testing as a CRC screening test is uncertain. We designed a randomized trial to compare participation rate, detection rates, and costs between CTC (with computer-aided detection) and FS as primary tests for population-based screening.Methods/Design: An invitation letter to participate in a randomized screening trial comparing CTC versus FS will be mailed to a sample of 20,000 people aged 58 or 60 years, living in the Piedmont region and the Verona district of Italy. Individuals with a history of CRC, adenomas, inflammatory bowel disease, or recent colonoscopy, or with two first-degree relatives with CRC will be excluded from the study by their general practitioners. Individuals responding positively to the invitation letter will be then randomized to the intervention group (CTC) or control group (FS), and scheduled for the screening procedure. The primary outcome parameter of this part of the trial is the difference in advanced neoplasia detection between the two screening tests. Secondary outcomes are cost-effectiveness analysis, referral rates for colonoscopy induced by CTC versus FS, and the expected and perceived burden of the procedures. To compare participation rates for CTC versus FS, 2,000 additional eligible subjects will be randomly assigned to receive an invitation for screening with CTC or FS. In the CTC arm, non-responders will be offered fecal occult blood test (FOBT) as alternative screening test, while in the FS arm, non-responders will receive an invitation letter to undergo screening with either FOBT or CTC. Data on reasons for participation and non-participation will also be collected.Discussion: This study will provide reliable information concerning benefits and risks of the adoption of CTC as a mass screening intervention in comparison with FS. The trial will also evaluate the role of computer-aided detection in a screening setting.Trial registration: ClinicalTrials.gov Identifier: NCT01739608.

KW - Colorectal cancer

KW - Computer-aided detection

KW - CT colonography

KW - Flexible sigmoidoscopy

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=84897934304&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897934304&partnerID=8YFLogxK

U2 - 10.1186/1745-6215-15-97

DO - 10.1186/1745-6215-15-97

M3 - Article

C2 - 24678896

AN - SCOPUS:84897934304

VL - 15

JO - Trials

JF - Trials

SN - 1745-6215

IS - 1

M1 - 97

ER -